| Detected | Trial | Change |
|---|---|---|
| 2026-08-08 | NCT07359846 A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe… |
Trial sites expanded: 51 -> 59 locations |
| 2026-08-07 | NCT07359846 A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe… |
Trial sites expanded: 34 -> 51 locations |
| 2026-08-04 | NCT07276724 A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe… |
Trial sites expanded: 53 -> 67 locations |
| 2026-07-21 | NCT07276724 A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe… |
Trial sites expanded: 35 -> 53 locations |
| 2026-07-21 | NCT07359846 A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe… |
Trial sites expanded: 16 -> 34 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07276724 | A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe… | Severe Asthma | Recruiting |
| NCT07359846 | A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe… | Severe Asthma | Recruiting |
| Phase 1 | |||
| NCT07484022 | Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer | Advanced Urothelial Cancer | Recruiting |
| NCT07116889 | A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD | Asthma | Active, Not Recruiting |
| NCT06920693 | Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy… | Atopic Dermatitis (AD) | Active, Not Recruiting |